Safety and clinical activity of MK-3475 as initial therapy in patients with advanced non-small cell lung cancer (NSCLC).
暂无分享，去创建一个
M. Dolled-Filhart | K. Emancipator | N. Rizvi | K. Papadopoulos | A. Patnaik | L. Gandhi | A. Balmanoukian | J. Eder | N. Leighl | J. Goldman | R. Hui | E. Garon | M. Gubens | Jin Zhang | G. Lubiniecki | G. Blumenschein | M. Hanson | Elizabeth A. Johnson | Michelle Niewood